Menzella, F., Piro, R., Facciolongo, N., Castagnetti, C., Simonazzi, A., & Zucchi, L. (2011). Long-term benefits of omalizumab in a patient with severe non-allergic asthma. BioMed Central.
Chicago Style CitationMenzella, Francesco, Roberto Piro, Nicola Facciolongo, Claudia Castagnetti, Anna Simonazzi, i Luigi Zucchi. Long-term Benefits of Omalizumab in a Patient With Severe Non-allergic Asthma. BioMed Central, 2011.
Cita MLAMenzella, Francesco, et al. Long-term Benefits of Omalizumab in a Patient With Severe Non-allergic Asthma. BioMed Central, 2011.
Atenció: Aquestes cites poden no estar 100% correctes.